288 related articles for article (PubMed ID: 28782486)
1. NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.
Ju Hwang C; Choi DY; Park MH; Hong JT
CNS Neurol Disord Drug Targets; 2019; 18(1):3-10. PubMed ID: 28782486
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Alzheimer's disease.
Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
[TBL] [Abstract][Full Text] [Related]
3. UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS.
Verma Y; Sachdeva H; Kalra S; Kumar P; Singh G
Georgian Med News; 2023 Sep; (342):133-141. PubMed ID: 37991969
[TBL] [Abstract][Full Text] [Related]
4. Brain region- and sex-specific alterations in mitochondrial function and NF-κB signaling in the TgCRND8 mouse model of Alzheimer's disease.
Djordjevic J; Thomson E; Chowdhury SR; Snow WM; Perez C; Wong TP; Fernyhough P; Albensi BC
Neuroscience; 2017 Oct; 361():81-92. PubMed ID: 28802916
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
Thawkar BS; Kaur G
J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection.
Kaur U; Banerjee P; Bir A; Sinha M; Biswas A; Chakrabarti S
Curr Top Med Chem; 2015; 15(5):446-57. PubMed ID: 25620241
[TBL] [Abstract][Full Text] [Related]
7. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
[TBL] [Abstract][Full Text] [Related]
8. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.
Seo EJ; Fischer N; Efferth T
Pharmacol Res; 2018 Mar; 129():262-273. PubMed ID: 29179999
[TBL] [Abstract][Full Text] [Related]
9. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway.
Yang R; Liu S; Zhou J; Bu S; Zhang J
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):276-284. PubMed ID: 28669260
[TBL] [Abstract][Full Text] [Related]
11. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway.
Gu SM; Lee HP; Ham YW; Son DJ; Kim HY; Oh KW; Han SB; Yun J; Hong JT
Neuromolecular Med; 2018 Sep; 20(3):312-327. PubMed ID: 29802525
[TBL] [Abstract][Full Text] [Related]
13. Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease.
Shi ZM; Han YW; Han XH; Zhang K; Chang YN; Hu ZM; Qi HX; Ting C; Zhen Z; Hong W
J Neurol Sci; 2016 Jul; 366():127-134. PubMed ID: 27288790
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line.
Gao F; Bales KR; Dodel RC; Liu J; Chen X; Hample H; Farlow MR; Paul SM; Du Y
Brain Res Mol Brain Res; 2002 Sep; 105(1-2):108-14. PubMed ID: 12399113
[TBL] [Abstract][Full Text] [Related]
15. The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease.
Sun E; Motolani A; Campos L; Lu T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012242
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) - a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease.
Marwarha G; Ghribi O
CNS Neurol Disord Drug Targets; 2017; 16(10):1050-1065. PubMed ID: 28745240
[TBL] [Abstract][Full Text] [Related]
17. Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Srinivasan M; Lahiri DK
Expert Opin Ther Targets; 2015 Apr; 19(4):471-87. PubMed ID: 25652642
[TBL] [Abstract][Full Text] [Related]
18. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex.
Lukiw WJ; Bazan NG
J Neurosci Res; 1998 Sep; 53(5):583-92. PubMed ID: 9726429
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease.
Yoshiyama Y; Arai K; Hattori T
Neuroreport; 2001 Aug; 12(12):2641-5. PubMed ID: 11522940
[TBL] [Abstract][Full Text] [Related]
20. Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer's disease via SIRT1/NF-κB pathway.
Gao J; Zhou R; You X; Luo F; He H; Chang X; Zhu L; Ding X; Yan T
Metab Brain Dis; 2016 Aug; 31(4):771-8. PubMed ID: 26909502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
